NCT00125255View on ClinicalTrials.gov

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Pain
Interventions
DRUG

S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)

S-Caine Peel comprising of a 1:1 eutectic mixture of 7% lidocaine and 7% tetracaine was applied topically. The study drug was applied at approximately 1 mm in thickness and remained on the treatment area for 30 minutes

DRUG

Placebo Peel

Placebo Peel applied topically at approximately 1 mm in thickness and remained on the treatment area for 30 minutes

Trial Locations (1)

02115

Children's Hospital, Boston

All Listed Sponsors
lead

ZARS Pharma Inc.

INDUSTRY

NCT00125255 - S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children | Biotech Hunter | Biotech Hunter